Clinical Trial Update: Effect of Catheter-based Radiofrequency Ablation Therapy in Patient With Therapy-resistant Hypertension and Sleep Apnea Syndrome

View source ↗

Summary

The clinical trial investigating catheter-based radiofrequency ablation for therapy-resistant hypertension and sleep apnea was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Obstructive Sleep Apnea

Snippet

Sponsor: University of Zurich | Conditions: Therapy-resistant Hypertension and Sleep Apnea | Status: WITHDRAWN